Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
IMUX similar filings
- 20 Oct 20 EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
- 11 Sep 20 Regulation FD Disclosure
- 10 Aug 20 Entry into a Material Definitive Agreement
- 3 Aug 20 Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis
- 27 Jul 20 Regulation FD Disclosure
- 7 Jul 20 Submission of Matters to a Vote of Security Holders
- 19 Jun 20 Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19
Filing view
External links
